Navigation Links
BD Launches BD MAX™ Open System in Europe and Reveals Strategy to Build Broad Menu of Assays that Provide Timely, Accurate Information to Laboratories and Clinicians
Date:5/6/2011

s "plan", "intend" or words of similar meaning in conjunction with statements of future performance. All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. With respect to forward-looking statements contained herein, a number of factors could cause actual results to vary materially from any forward-looking statement. These factors include, but are not limited to:  difficulties inherent in product development and delays in product introductions; the possibility that BD may not be able to enter into product development agreements on satisfactory terms; the unknown consequences of the recently-enacted healthcare reform in the United States, including potential reduced demand for BD's products; adverse changes in regional, national or foreign economic conditions, including any impact that may result from the current global economic situation on BD's ability to access credit markets and finance its operations, the demand for BD's products and services, or its suppliers' ability to provide products needed for BD's operations; competitive factors; pricing and market share pressures; increases in energy costs and their effect on, among other things, the cost of producing BD's products; fluctuations in costs and availability of raw materials and in BD's ability to maintain favorable supplier arrangements and relationships; new or changing laws impacting BD's business or changes in enforcement practices with respect to such laws; and future healthcare reform, including changes in government pricing and reimbursement policies or other cost containment reforms. BD does not intend to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by applicable laws or regulations.

Contact:
Vikki Lomas
C
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quest Diagnostics Launches Simplexa™ C. Difficile Universal Direct Test in Europe
2. Bacterin International Holdings Launches Third Biologic Scaffold
3. Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians
4. Remedi SeniorCare® Launches Electronic Order Entry Capability as Part of the My Remedi® Suite of Online Tools
5. Nonin Medical Launches Low Power Xpod®, Model 3012LP, OEM Pulse Oximeter Globally
6. Netsmart Technologies Launches Exchange for Customers to Share Applications and Information
7. Watson Launches Generic Concerta®
8. Masimo Launches New Reusable SpCO® Sensor with Improved Accuracy and Reliability in Low Oxygen Saturation and Elevated Methemoglobin States
9. CryoLife Launches BioGlue® Surgical Adhesive in Japan
10. Mylan Launches First Generic Version of Femara® Tablets
11. Mylan Launches Generic Version of Famvir® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 The role of the ... but one thing hasn,t changed: face-to-face meetings are seen ... with Key Opinion Leaders. Yet at the ... valuable type of interaction, field medical teams within the ... interactions. This is just one of the challenges addressed ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... published in the Proceedings of the National ... showed when ibrutinib (IMBRUVICA ® ) was combined ... of tumor growth was enhanced suggesting a greater ... cancers and solid tumors with the combination. IMBRUVICA ...
(Date:2/27/2015)... 2015 - ... di monitoraggio dell,infarto congestizio (CHF - Congestive Heart ...     Vectorious Medical Technologies, ... per il monitoraggio cardiaco destinato a pazienti affetti ... aver concluso una raccolta di finanziamenti per 5 ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... Nov. 2, 2010 Hanger Orthopedic Group, Inc. (NYSE: ... York City time, on Monday, November 1, 2010 (the "Early ... Notes due 2014 (the "Notes") have been validly tendered and ... tender offer (the "Offer") for any and all of its ...
... and BUDAPEST, Hungary, November 2, 2010 ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014 2Hanger Orthopedic Group, Inc. Announces Early Tender Results of Offer to Purchase Outstanding 10-1/4% Senior Notes Due 2014 3National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 2National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 3National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 4National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 5National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 6National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 7National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 8National Institute of Advanced Industrial Science and Technology (AIST) Adopts ChemAxon JChem Base for Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB) 9
(Date:2/28/2015)... March—also known as National Brain Injury ... and others that suspected head injuries, especially concussions, ... , Concussions are a form of traumatic brain ... There are 1.6-3.8 million sports-related concussions per year. ... is a brain injury. Many athletes suffer knee ...
(Date:2/28/2015)... 28, 2015 Vancouver personal injury lawyers at ... are affected by time limits. They stated that in many ... claim or even nullify it. Many a time, delays in ... client’s rights under BC law. As a result, experts at ... accidents should consult a personal injury lawyer in order to ...
(Date:2/28/2015)... 28, 2015 A study out of ... gene therapy procedure for the treatment of a hereditary ... Authored by Dr. Robert MacLaren, professor of ... the Lancet Medical Journal on January 16, 2014 , ... rare genetic disorder that mostly affects men and leads ...
(Date:2/28/2015)... The Mesothelioma Applied Research Foundation ... International Symposium on Malignant Mesothelioma on Monday, March 2. ... Regency Bethesda in Bethesda, Maryland. The following award recipients ... to the mission to cure mesothelioma. , The Klaus ... to Miriam Ratner. Miriam runs the Meso Foundation’s monthly ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 ... of outsourced sales, marketing and supply chain management ... BIOTA Botanicals, is bringing its award winning solutions ... BIOTA Botanicals’ products are specifically created to combat ... experts, BIOTA is committed to marrying science with ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3
... ... it,s new shop in Beverly Hills, featuring old style barbering, straight razor shaves, in a ... ... today the official opening of its Beverly Hills store located at 9635 Brighton Way, Beverly ...
... ... Everyone,The largest and most exciting health fair ever to be held in Clark County is being ... Kids, sports fans, senior citizens, gun owners, dog lovers, teenage drivers, moms, and dads will all ... ...
... ... ... , ... , , , , ...
... ... the stem cell revolution, is on a 10 city speaking/book tour including Spokane. He will ... ... the stem cell phenomenon made a science book an overnight Amazon Best Seller and catapulted ...
... ... ... ... , ...
... ... ... ... ...
Cached Medicine News:Health News:The Classic Shave Company Announces the Opening of Beverly Hills Shop 2Health News:Vancouver, Washington -- Free Family Fun at Health Fair 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 260,500 Square Foot Medical Office Portfolio in Indiana 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 260,500 Square Foot Medical Office Portfolio in Indiana 3Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire an Approximately 260,500 Square Foot Medical Office Portfolio in Indiana 4Health News:Health: Surprise Best Seller is Stem Cell Book – Author in Spokane - 10 City Tour 2Health News:WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010 2Health News:WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010 3Health News:Medicare Advantage Members May Make Changes During Open Enrollment 2Health News:Medicare Advantage Members May Make Changes During Open Enrollment 3
Flat handle....
Thin and smooth jaws, cross action....
Angled shafts, smooth jaws, polished finish....
... This direct-acting inserter grasps the thinnest ... rim, resulting in a minimum incision requirement. ... around the thicker center of the optic ... optic, resulting in delivery of an implant ...
Medicine Products: